Christopher Mason
Director · Krystal Biotech, Inc.
Individual
- 2026
- Sep 17, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Christopher Mason files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Suma Krishnan - $34.27M in KRYS purchases and sales in the last 12 months
- Krish S. Krishnan - $34.27M in KRYS purchases and sales in the last 12 months
- Daniel Janney - $19.40M in KRYS purchases and sales in the last 12 months
- Dino A. Rossi - $13.18M in KRYS purchases and sales in the last 12 months
- Kathryn Romano - $3.60M in KRYS purchases and sales in the last 12 months
- John Charles Thomas - $541K in KRYS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Christopher Mason?
Christopher Mason is a corporate insider, tracked as Director of Krystal Biotech, Inc. (KRYS). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Christopher Mason submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.